(E)-Ethoxy(1-{3-methyl-5-thia-2,7-diazatricyclo[6.4.0.0^{2,6}]dodeca-1(8),3,6,9,11-pentaen-4-yl}ethylidene)amine

Catalog No. :
ACBHOB216
CAS No. :
478063-09-1
Molecular Formula :
C14H15N3OS
Molecular Weight :
273.36

IUPAC Name:(E)-1-(3-methylbenzo[4,5]imidazo[2,1-b]thiazol-2-yl)ethan-1-one O-ethyl oxime

(E)-Ethoxy(1-{3-methyl-5-thia-2,7-diazatricyclo[6.4.0.0^{2,6}]dodeca-1(8),3,6,9,11-pentaen-4-yl}ethylidene)amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$287.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-Ethoxy(1-{3-methyl-5-thia-2,7-diazatricyclo[6.4.0.0^{2,6}]dodeca-1(8),3,6,9,11-pentaen-4-yl}ethylidene)amine
IUPAC Name(E)-1-(3-methylbenzo[4,5]imidazo[2,1-b]thiazol-2-yl)ethan-1-one O-ethyl oxime
Molecular FormulaC14H15N3OS
Molecular Weight273.36
SMILESC/C(C1=C(C)N2C3=CC=CC=C3N=C2S1)=N\OCC
InChI KeySWVWTYUEWDFMJA-CXUHLZMHSA-N
Synonym1-(3-METHYL[1,3]THIAZOLO[3,2-A][1,3]BENZIMIDAZOL-2-YL)-1-ETHANONE O-ETHYLOXIME;(E)-ethoxy(1-{3-methyl-5-thia-2,7-diazatricyclo[6.4.0.0^{2,6}]dodeca-1(8),3,6,9,11-pentaen-4-yl}ethylidene)amine;Ethanone, 1-(3-methylthiazolo[3,2-a]benzimidazol-2-yl)-, O-ethyloxime
CAS No.478063-09-1

Synthetic Route by SureRoute

1. ACBHOB216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXZLA542 route compound structure diagram
    ACXZLA542134469-07-1 In Stock
  4. Then
  5. ACBHOB216 route product structure diagram
    ACBHOB216478063-09-1
Inquiry

2. ACBHOB216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGROX251 route compound structure diagram
    ACGROX251624-86-2 In Stock
  4. Then
  5. ACBHOB216 route product structure diagram
    ACBHOB216478063-09-1
Inquiry

Comments (0)